相关实验视频
Updated: Jun 11, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.6K
对代谢 - 腹部外科手术后管理怀孕的临床实践指南进行系统审查
Raheleh Moradi1, Maryam Kashanian2, Ali Sheidaei3
1Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
Obesity (Silver Spring, Md.)
|October 1, 2024
概括
这次审查发现,在减肥手术后管理怀孕的临床实践指南是一致的,强调避孕和营养支持. 需要进一步的研究来解决诸如怀孕时间和新生儿护理等领域的不一致性.
科学领域:
- 腹部外科和产科 腹部外科和产科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 肥胖率的上升推动了生育年龄妇女的减肥手术的增加.
- 代谢腹腔外科手术后的怀孕带来了独特的管理挑战.
研究的目的:
- 审查临床实践指南 (CPG),以管理代谢-腹腔外科手术后的怀孕.
- 评估现有指南的质量和一致性.
主要方法:
- 关于CPG的综合文献搜索 (2010-2022年).
- 使用研究和评估指南评估II (AGREE II) 工具得分的质量和有用性.
- 由两位作者进行的独立评审.
主要成果:
- 一致的建议:怀孕前避孕,营养师主导的营养护理,将胃肠道问题视为手术并发症,以及改进的妊娠糖尿病查.
- 在手术到怀孕间隔和补充剂剂量中发现的不一致性.
- 在手术类型,心理健康,分娩,母乳养,新生儿护理和体重保持方面发现了研究缺口.
结论:
- 现有的CPG提供了临床上有用的建议,用于怀孕后腹腔外科手术.
- 应该执行一致的建议.
- 不一致的领域需要集中研究努力.
相关概念视频
Pathophysiology of Diabetes
894
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Acute Pancreatitis II: Clinical Manifestations and Management
95
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
95
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Oral Hypoglycemic Agents: Biguanides and Glitazones
181
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
181

